GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Locally Advanced or Metastatic Breast Cancer
Interventions: DRUG: GB491+ Fulvestrant|DRUG: Placebo+Fulvestrant
Sponsor: Genor Biopharma Co., Ltd.